Carboplatin Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Apr 28, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-4248-01
Dosage Form
Injection
Presentation
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)
Initial Posting
Apr 28, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.